Bouhaddou et al.12
|
Time series without external control |
Improved; indication of surgery |
Improved; rate of request for surgery, mixed; increased preauthorization approval rate |
Improved |
Cost increased |
Burack et al.13
|
RCT by patient |
Nd |
Increased use of mammography in health department setting, but not in HMO setting |
Nd |
Nd |
Burack and Gimotty14
|
|
|
|
|
|
Day et al.15
|
Time series without external control |
Improved after-care instructions |
No effect |
Nd |
No effect on cost |
Dexter et al.16
|
RCT by provider team |
Nd |
Increased discussion with intervention (24% vs. 4% without) |
Nd |
Improved rate of advance directive completion, 4% vs. 15% |
Goethe et al.18
|
Time series without external control |
Nd |
Improved response to alerts |
Nd |
Nd |
Litzelman et al.19
|
RCT by provider team |
Nd |
Improved mammography and fecal occult blood testing; no effect on Pap testing |
Nd |
Nd |
Lobach and Hammond20
|
RCT by clinician |
Nd |
Two-fold increase in compliance with guidelines for 3 of 8 standards; failure for 5 of 8 |
Nd |
Nd |
Margolis et al.21
|
Time series without external control |
Improved; 3 of 6 diseases |
Improved for 2 of 6 diseases; decreased inappropriate use of antibiotics for 2 diseases |
Too tedious, physicians refused to continue |
Nd |
Nilasena et al.22
|
RCT by physician |
Nd |
Improved average total compliance score for both control and intervention |
70% found forms difficult to use and did not reduce time to provide care |
Nd |
Nilasena and Lincoln23
|
|
|
|
|
|
Ornstein et al.25
|
Time series without external control |
Nd |
Improved compliance with counseling, screening tests, breast exams, and thyroid function tests; no change for immunizations, fecal occult blood, Pap smear, mammography |
No improvement in patient's perceived preventive services delivery |
Nd |
Overhage et al.26
|
RCT by provider team |
Nd |
No effect: control, 24% compliance rate; intervention, 23% |
Nd |
Nd |
Robbins et al.27
|
Time series without external control |
Nd |
Nd |
Nd |
Cholesterol, LDL, and triglycerides levels decreased; HDL increased |
Rossi and Every28
|
RCT by provider |
Nd |
Improved: 11.3% of patients changed to first line antihypertensive drugs |
Nd |
No significant change in BP |
Safran et al.29
|
RCT by site |
Nd |
Improved: response time to alerts, 52 vs. 11 days |
Nd |
No change in admission rates, ER visits, survival or pneumocystis admissions |
Schriger et al.30
|
Time series with switchback |
Improved for 6 of 7 history items |
Improved: 4 laboratory tests; 4 of 5 treatments |
Nd |
Cost: charges decreased for laboratory and prescriptions |
Tape and Campbell31
|
Nonrandomized controlled trial by provider team |
Nd |
Improved sigmoidoscopy and immunization rates; no change in thyroxine, Pap, mammography, fecal occult blood screening |
Nd |
Nd |
Turner et al.32
|
RCT by physician |
Nd |
Small improvement in health maintenance activities |
Nd |
Nd |
Vincent et al.33
|
Time series without external control |
Nd |
Improved provider compliance; patient compliance improved for some |
Nd |
Nd |
Willson et al.34
|
Time series without external control |
Nd |
Improved for both prevention and treatment protocols |
Nd |
Decrease in incidence of pressure ulcers |
Zielstorff et al.36
|
Time series with control
|
Nd
|
No effect: clinical decision making
|
Positive for instructional adequacy and user satisfaction
|
Nd
|
Note: BP indicates blood pressure; Nd, not discussed; HDL, high-density lipoprotein; LDL, low-density lipoprotein; RCT, randomized controlled trial. |